BGNE - BeiGene Ltd Stock Trading

BeiGene Ltd.(NASDAQ: BGNE) stock trading, description, contact, officers and directors.

About BeiGene Ltd.

Not available

Stock Information

BeiGene Ltd. Company Name:

BGNE Stock Symbol:

NASDAQ Market:

Get BGNE Alerts

News, Short Squeeze, Breakout and More Instantly...

BGNE - BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

Trial met the primary endpoint at interim analysis, with BRUKINSA significantly prolonging progression-free survival compared to chemoimmunotherapy and safety and tolerability consistent with its known profile SEQUOIA is the second positive global Phase 3 trial of BRUKINSA in ...
BGNE - Why BeiGene Stock Soared Today

Shares of BeiGene (NASDAQ: BGNE) were soaring 15.6% higher as of 3:38 p.m. EDT on Wednesday. The big jump came after the Chinese drugmaker filed a document to the U.S. Securities and Exchange Commission (SEC) related to the proposed public offering of its stock and listing on the Sc...
BGNE - BeiGene Announces Approval in Canada of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Mantle Cell Lymphoma

Second approval for BTK Inhibitor BRUKINSA in Canada BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today ann...